Supplementary Table 1 from A Novel Tankyrase Inhibitor Decreases Canonical Wnt Signaling in Colon Carcinoma Cells and Reduces Tumor Growth in Conditional APC Mutant Mice by Jo Waaler (1970758)

Figure 4 from PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma by Khaled Mohamed Nassar (19810317)

Figure 2 from PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma by Khaled Mohamed Nassar (19810317)

S4. IGF-1R inhibition did not decrease FoxO1 protein levels in MCF-7 cells. from IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer Cells by Ali Vaziri-Gohar (13862857)

Subjects:

FIGURE 2 from Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects by Alexandria P. Eiken (18597722)

Analysis heat map of skeletal muscle and myocardial related factors in C57BL6 mice. by Jingxuan Wang (435196)

Subjects:

Figure S4 from Exome Sequencing of Plasma DNA Portrays the Mutation Landscape of Colorectal Cancer and Discovers Mutated VEGFR2 Receptors as Modulators of Antiangiogenic Therapies by Rodrigo A. Toledo (14996709)

Subjects:

Figure S1 from The <i>MCT4</i> Gene: A Novel, Potential Target for Therapy of Advanced Prostate Cancer by Stephen Yiu Chuen Choi (14996076)

Figure S6 from Exome Sequencing of Plasma DNA Portrays the Mutation Landscape of Colorectal Cancer and Discovers Mutated VEGFR2 Receptors as Modulators of Antiangiogenic Therapies by Rodrigo A. Toledo (14996709)

Subjects:

Supplementary Table 1-2, Figures S1-4 from siRNA Lipid Nanoparticle Potently Silences Clusterin and Delays Progression When Combined with Androgen Receptor Cotargeting in Enzalutam... by Yoshiaki Yamamoto (2920581)

Subjects:

Table_1_Targeting metabolic pathways: a novel therapeutic direction for type 2 diabetes.docx by Zhihui Song (8270244)

Table_2_Targeting metabolic pathways: a novel therapeutic direction for type 2 diabetes.docx by Zhihui Song (8270244)

Table_3_Targeting metabolic pathways: a novel therapeutic direction for type 2 diabetes.docx by Zhihui Song (8270244)

Figure S4 from Targeting DNMTs to Overcome Enzalutamide Resistance in Prostate Cancer by Elia Farah (14933502)

Subjects:

Supplementary Data from HDAC8 Regulates a Stress Response Pathway in Melanoma to Mediate Escape from BRAF Inhibitor Therapy by Michael F. Emmons (14935638)

Subjects:

Circulating Th17.1 cells as candidate for the prediction of therapeutic response to abatacept in patients with rheumatoid arthritis: An exploratory research by Shinji Maeda (445222)

Supplemental Figures from Rictor/mTORC2 Drives Progression and Therapeutic Resistance of <i>HER2</i>-Amplified Breast Cancers by Meghan Morrison Joly (4218496)

Subjects:

Data Supplement from Selective Release of a Cyclopamine Glucuronide Prodrug toward Stem-like Cancer Cell Inhibition in Glioblastoma by Anaïs Balbous (3425822)

Subjects:

Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…</p>Methods<p>Publications from 1 January 2013 to 31 December 2023 that described clinical research of AGs were identified by searching the Web of Science Core Collection Database. …”

Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…</p>Methods<p>Publications from 1 January 2013 to 31 December 2023 that described clinical research of AGs were identified by searching the Web of Science Core Collection Database. …”